Outlining the Developmental Landscape of Next Generation Viral Vectors

Time: 12:00 pm
day: Conference Day One


  • Benchmarking the state of development of novel viral vectors for use in neurological gene therapies
  • Reimagining novel engineered viral vectors for improved targeting and delivery across the blood brain barrier
  • Exploring the future of viral vector delivery of gene therapies to the CNS